Tofacitinib- A First-In-Class Drug for Rheumatoid Arthritis

Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2017, Vol 16, Issue 3

Abstract

Rheumatoid arthritis (RA) is a chronic, systemic and disabling autoimmune inflammatory disease characterized by inflammation of the synovial lining of the joints, tendons and periarticular structure affecting approximately 1% of the population world-wide. Tofacitinib is a novel oral Janus-kinase inhibitor approved for the treatment of RA patients as a second line therapy in those who fail to respond to methotrexate therapy. Clinical trials with tofacitinib have shown reasonable efficacy. However, the drug’s greatest limitation is its potential to induce cancers and latent infections could be reactivated. Nevertheless, the drug can slow the progression of the disease and has evoked lot of interest due to the fact that it is a first in class molecule for the treatment of rheumatoid arthritis.

Authors and Affiliations

Sujithera Haridoss, Melvin George, Damal Kandadai Sriram

Keywords

Related Articles

Compliance to Head and Neck Radiotherapy in Our Patient Population

Background: The treatment of head and neck cancer is complex, costly, toxic and challenging particularly in this part of the world where majority of the patients are from rural background and lower socioeconomic status....

The Optimum Solution of Degenerate Transportation Problem

The Solution of a Transportation Problem is obtained in two phases. The first phase is finding the initial basic feasible solution by using various methods. The optimal solution is obtained either by using stepping stone...

Quality Of Life of Patients with Type 2 Diabetes

Introduction: Quality of life is important for people with diabetes and their healthcare providers for several reasons. This is because many people who suffer from diabetes and who have poor quality of life, often have l...

Immunohistochemical Expression of Matrix Metalloproteinase-2 (MMP-2) in Benign Ovarian Cyst at Adam Malik General Hospital in 2017

Objective: To determine the immunohistochemical expression of matrix metalloproteinase-2 (MMP-2) in benign ovarian cyst tissue at Adam Malik General Hospital in 2017 Material and Method: This study was an retrospective o...

Associative Study of Fine Needle Aspiration Cytology of Thyroid with Histopathological Study – A Prospective Study

Introduction:- Thyroid diseases are frequently encountered endocrine disorders in clinical practice. Majority of these are benign, of which goitre is the commonest. Only a few are malignant. Clinical evaluation helps in...

Download PDF file
  • EP ID EP591706
  • DOI 10.9790/0853-160301106108
  • Views 76
  • Downloads 0

How To Cite

Sujithera Haridoss, Melvin George, Damal Kandadai Sriram (2017). Tofacitinib- A First-In-Class Drug for Rheumatoid Arthritis. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 16(3), 106-108. https://www.europub.co.uk/articles/-A-591706